Acura Pharma (ACUR) Tops Q3 EPS by 8c

November 14, 2016 4:37 PM EST
Get Alerts ACUR Hot Sheet
Trade ACUR Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Acura Pharma (NASDAQ: ACUR) reported Q3 EPS of ($0.19), $0.08 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $218 thousand versus the consensus estimate of $230 thousand.

For earnings history and earnings-related data on Acura Pharma (ACUR) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment